Esperion Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ESPR and other ETFs, options, and stocks.About ESPR
Esperion Therapeutics, Inc. is a pharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets.
ESPR Key Statistics
Stock Snapshot
Esperion Therapeutics(ESPR) stock is priced at $3.08, giving the company a market capitalization of 727.95M. It carries a P/E multiple of -5.67.
During the trading session on 2026-03-10, Esperion Therapeutics(ESPR) shares reached a daily high of $3.06 and a low of $2.63. At a current price of $3.08, the stock is +17.1% higher than the low and still +0.7% under the high.
Trading activity shows a volume of 7.41M, compared to an average daily volume of 4.84M.
Over the past 52 weeks, Esperion Therapeutics(ESPR) stock has traded between a high of $4.18 and a low of $0.69.
Over the past 52 weeks, Esperion Therapeutics(ESPR) stock has traded between a high of $4.18 and a low of $0.69.
ESPR News
Reports Q4 revenue $168.4M, consensus $166.12M. “2025 was a defining year for Esperion (ESPR). We delivered strong growth in our U.S. cardiovascular franchise,...
06:03 EDT Esperion (ESPR) sees 2026 operating expenses $225M-$255M vs. $343M in 2025 Published first on TheFly – the ultimate source for real-time, market-movi...
Esperion, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Paul Choi from Goldman Sachs maintained a Hold rating on the...
Analyst ratings
71%
of 7 ratingsMore ESPR News
Esperion Therapeutics, Inc. (NASDAQ:ESPR) shares are down during Tuesday’s premarket session as the company announced a definitive agreement to acquire Corstasi...
The latest update is out from Esperion ( (ESPR) ). On March 2, 2026, Esperion Therapeutics, Inc. signed a definitive agreement to acquire privately held Corsta...
Esperion (ESPR) has entered into a definitive agreement to acquire Corstasis Therapeutics, a privately-held, commercial-stage biopharmaceutical company advancin...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.